Can Diagnostics Aid in Alleviating Antimicrobial Resistance and Sepsis?
Antimicrobial resistance (AMR) continues to be an increasingly significant public health issue, leading to higher mortality rates. One study estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.1 Untreated or undertreated bacterial infections are a major cause of sepsis—a serious complication that places a […]
How antibiotic resistance to fusidic acid works
In a new article published in Nature Communications, researchers from Uppsala Antibiotic Center, Uppsala University and SciLifeLab describe a fundamental mechanism of antibiotic resistance. What happens in a bacterium that is resistant to the antibiotic fusidic acid? With a stop-motion movie at the atomic level, they can show that the resistance protein FusB works nearly […]
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
More than 80% of adults in Sierra Leone said they would accept COVID-19 vaccines for themselves or their families, according to a study presented at the 2025 Annual Conference on Vaccinology Research. The study surveyed 2,146 adults to assess vaccine awareness, acceptance, and hesitancy. Researchers from Emory University, the University of Siena, and other institutions […]
Communicable disease threats report, 10-16 May 2025, week 20
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, Middle East respiratory syndrome coronavirus (MERS-CoV), avian influenza A(H10N3 and H9N2) and diphtheria, chikungunya virus disease, measles, and Nipah virus disease. Source link
Overcoming Barriers and Embracing Long-Acting PrEP
Zandraetta Tims-Cook, MD, MPH, an infectious diseases physician focused on HIV health disparities in Atlanta, has dedicated her career to HIV prevention and outreach, particularly for women living with HIV. Since 2008, she has worked to bridge gaps in care and improve prevention strategies for high-risk populations. In our interview, Tims-Cook discussed overcoming barriers to […]
Early Release – Art of the Interwoven – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA Sarah Hunter (1883–1967), Jar-shaped Basket, 1910. Willow, bulrush; coiled (3 rods), 4 15/16 in x 7 […]
Early Release – Prevalence of Nitroimidazole-Refractory Giardiasis Acquired in Different World Regions, Sweden, 2008–2020 – Volume 31, Number 6—June 2025 – Emerging Infectious Diseases journal
Giardia intestinalis (G. lamblia, G. duodenalis) is an intestinal protozoal pathogen found worldwide; the highest incidence occurs in developing countries. For decades, the first-line treatment for giardiasis has been the 5-nitroimidazoles, such as metronidazole and tinidazole (1). Since the early 2000s, reports of giardiasis refractory (resistant) to 5-nitroimidazoles have increased, posing a clinical challenge. The […]
New Oral Antibiotic for Gonorrhea on the Horizon
A first-in-class oral antibiotic showed promise treating gonorrhea in a randomized clinical trial, possibly offering the only new antibiotic treatment for the sexually transmitted infection (STI) in about 20 years. Source link
